K. Ajiki

Possible mechanism and clinical characteristics of idiopathic ventricular tachycardia

L. Fu, T. Namiki, Kazuzo Kato, 1992 .

Analysis of bioMARKer Distribution and Individual Reproducibility Under Rivaroxaban Treatment in Japanese Patients with Non-Valvular Atrial Fibrillation (R-MARK Study, CVI ARO2).

Y. Hiroi, T. Yamashita, S. Suzuki, 2020, International heart journal.

Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J‐RHYTHM Registry

T. Osaka, N. Hagiwara, T. Nakamura, 2016, Journal of the American Heart Association.